Full tender Source status Β· 2 documents Β· Completeness: 45%
- ALL__A_-_istanza_di_partecipazione.doc (allegato, 1 pp.)
- AVVISO_-_ACT.doc (avviso, 1 pp.)
π΄ NO-GO
Focus: coagulazione POCT; test rapidi Β· Deadline: expired Β· Exclusivity risk: high
Preliminary market consultation expired since 06/02/2023 with a declared single operator and unique technical requirements: out of time and at high exclusivity risk.
π― Merit only (ignore deadline): NO-GO β Consultation with a declared single operator/unique requirements: opportunity effectively closed in substance, not only due to timing.
TENDER ANALYSIS No. 2023-02_Perugia
Document generated on 04/06/26
TENDER IDENTIFICATION DATA
| TENDER SUBJECT | Supply of "Analytical Systems for the determination of the coagulation time (ACT)" - Preliminary market consultation preparatory to a negotiated procedure without prior publication of a contract noticeSource: AVVISO_-_ACT.doc: pagina 1 |
| CONTRACTING AUTHORITY | Azienda Ospedaliera di Perugia - Purchasing and Procurement DepartmentSource: AVVISO_-_ACT.doc: pagina 1 |
| CIG (tender ID) | Not stated |
| PROCEDURE TYPE | Preliminary market consultation (art. 66 Legislative Decree 50/2016) preparatory to a negotiated procedure without prior publication of a contract notice pursuant to art. 63, paragraph 2, letter b), point 2) Legislative Decree 50/2016Source: AVVISO_-_ACT.doc: pagina 1 |
| PLATFORM | Submission via certified email (PEC) to the address acquistiappalti.aosp.perugia@postacert.umbria.it (operators declare registration with MePA Consip, "Beni" initiative)Source: AVVISO_-_ACT.doc: pagina 1 |
| PLACE OF PERFORMANCE | Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia, S. Andrea delle Fratte, 06132 PerugiaSource: AVVISO_-_ACT.doc: pagina 1 |
| AWARD CRITERION | Not stated |
| BID SUBMISSION DEADLINE | 7:00 PM on 6/02/2023 (deadline for responding to the preliminary market consultation)Source: AVVISO_-_ACT.doc: pagina 1 |
| TOTAL AMOUNT | Euro 36.000,00 excluding VAT per year (estimated base auction price for the annual requirement)Source: AVVISO_-_ACT.doc: pagina 1 |
| PNRR (recovery funds) | Not stated |
PARTICIPATION REQUIREMENTS
| ELIGIBILITY REQUIREMENTS | Registration with the Chamber of Commerce register (C.C.I.A.A.) for activities relating to the subject matter; registration with MePA Consip "Beni" initiative; entity referred to in art. 45 Legislative Decree 50/2016; possession of general requirements pursuant to art. 80 Legislative Decree 50/2016Source: ALL__A_-_istanza_di_partecipazione.doc: pagina 1 |
| ECONOMIC CAPACITY | Not stated |
| TECHNICAL CAPACITY | Submission of adequate technical documentation certifying the capacity to supply the requested systems, subject to assessment by expert personnelSource: AVVISO_-_ACT.doc: pagina 1 |
| SOA CATEGORY | Not stated |
| CREDIT LICENCE | Not stated |
| ADDITIONAL REQUIREMENTS | Not stated |
| WHITE LIST | Not stated |
PRELIMINARY OBLIGATIONS
| BID BOND | Not stated |
| ANAC FEE | Not stated (participation in the consultation does not entail charges for operators)Source: AVVISO_-_ACT.doc: pagina 1 |
| SITE INSPECTION | Not stated |
| SAMPLING | Not stated |
| TIMESTAMP / DIGITAL SIGNATURE | Not stated |
| TECHNICAL OFFER | Technical documentation required suitable to demonstrate compliance with the minimum technical requirements (not a binding offer - consultation phase)Source: AVVISO_-_ACT.doc: pagina 1 |
| STAMP DUTY | Not stated |
| LABOUR CONTRACT (CCNL) | Not stated |
| ACCELERATION BONUS | Not stated |
| SUBCONTRACTING | Not stated |
| RELIANCE (avvalimento) | Not stated |
| RTI / CONSORTIUM | In the case of a temporary grouping to be established, the application must be signed by all members of the groupingSource: ALL__A_-_istanza_di_partecipazione.doc: pagina 1 |
| CLARIFICATIONS DEADLINE | Not stated (administrative contacts: Dott. Glauco Fabbroni and Dott.ssa Beatrice Baldacci)Source: AVVISO_-_ACT.doc: pagina 1 |
| FVOE (virtual file) | Not stated |
Custom questions
Is this an awardable tender or a preliminary phase?
It is a preliminary market consultation (art. 66 Legislative Decree 50/2016) preparatory to a future negotiated procedure without a notice: it is not yet an awardable tender, but serves to confirm the non-substitutability or to identify additional operators able to supply the ACT system. Source: AVVISO_-_ACT.doc: pagina 1
Is there a risk of a single supplier/exclusivity?
Yes: the Authority declares that, based on the information in its possession, there would be a single economic operator able to provide the supply, the case under art. 63 par. 2 letter b) p.2). The minimum technical requirements are detailed (microdroplet system, ACT for high heparin dosages in half the time up to 350 sec). Source: AVVISO_-_ACT.doc: pagina 1
Who is the RUP (Procurement Officer) and how does one respond?
RUP: Dott. Glauco Fabbroni. The response must be sent via PEC by 7:00 PM on 6/02/2023 with a specific wording in the subject line. Source: AVVISO_-_ACT.doc: pagina 1
TECHNICAL ANALYSIS
Subject: Supply of Analytical Systems for the determination of the coagulation time (ACT) - preliminary market consultation preparatory to a negotiated procedureTotal base amount: β¬ 36.000,00 excluding VAT (annual, estimated base auction price)No. of lots: 1
LOT 1 β Analytical Systems for the determination of the coagulation time (ACT)
| CIG | Not stated |
| Description / what it is | Supply of POCT systems for measuring the activated coagulation time (ACT), typically used for monitoring high-dose heparin therapy (e.g. hemodynamics lab, cardiac surgery, dialysis). The ACT instrument and the consumables (cartridges/reagents) to run the tests are required. For technical/sales staff: it is a microdroplet coagulation POCT, a niche segment with a market controlled by few suppliers. |
| System / instrumentation | Portable microdroplet ACT instrument, with direct measurement of the fibrin clot, rechargeable lithium batteries, on-board barcode reader, dedicated port for data transmission, option for external printer |
| Base amount | β¬ 36.000,00 excluding VAT per year |
| Volumes | 4 Systems (instruments) and material for 4,500 tests per year (estimated annual requirement) |
| Duration | Not stated (requirement expressed on an annual basis) |
| Required tests | - Activated coagulation time (ACT)
- ACT for high heparin dosages (executed in half the time, up to 350 sec)
- Blood quality control
- Electronic quality control
|
| Technical requirements | - Microdroplet system
- Blood and electronic quality control tests
- Reduced interference from drugs or magnetic fields
- Storage of the patient test and the quality control
- Small instrument size and rechargeable lithium batteries
- Direct measurement of the fibrin clot
- On-board barcode reader
- Programming of automatic execution of internal electronic quality controls
- Traceability of operator, patient, quality control
- Data transmission with dedicated port
- Stability of reagents/cartridges at least 2 months at room temperature (sealed package)
- Stability of reagents/cartridges at least 24 hours once package is opened
- Option for external printer
- Execution of ACT test for high heparin dosages in half the time, up to 350 sec
|
| Sampling | Not stated (technical documentation required to substantiate the requirements) |
| Notes | SHOWSTOPPER: the Authority explicitly declares that there would be a SINGLE economic operator able to supply the system (premise of art. 63 par. 2 letter b p.2 - non-substitutability). The technical requirements are very specific (microdroplet, direct measurement of the fibrin clot, ACT high dosages in half the time up to 350 sec) and appear designed around a single technology/brand. Firsteck competitiveness very low unless an equivalent microdroplet ACT system is available in the portfolio. Furthermore, the phase is a market consultation closed on 6/02/2023, widely expired. |
| Sources | - AVVISO_-_ACT.doc: pagina 1
|
Assessment for Firsteck Bio
The product falls within the Firsteck focus as coagulation POCT (microdroplet ACT system, rapid point-of-care test). However, feasibility is practically nil: it is a preliminary market consultation expired more than three years ago (deadline 6/02/2023) and the Authority declares the existence of a single operator able to supply, with very stringent and effectively unique technical requirements. It makes sense only as market/historical information; it is not biddable.